Clarus Therapeutics Holdings Inc (CRXT) has fallen Monday morning, with the stock falling -25.00% in pre-market trading to 1.35. CRXT's short-term technical score of 67 indicates that the stock has traded more bullishly over the last month than 67% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 18 out of 146 industries, Clarus Therapeutics Holdings Inc ranks higher than 45% of stocks. Clarus Therapeutics Holdings Inc has risen 9.09% over the past month, closing at $1.89 on March 28. During this period of time, the stock fell as low as $0.85 and as high as $3.94. CRXT has an average analyst recommendation of Strong Buy. The company has an average price target of $7.20.
CRXT has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CRXT!